Policy Expert: FDA Nudging Tech Firms To Be More Proactive On Opioids

While tech companies are uniquely positioned to positively affect public health with regard to the opioid crisis, the industry remains somewhat hesitant to take on the role as content police, one policy expert told Inside Health Policy . The expert says FDA's recent opioid summit helped open the door for conversations, and she gives the agency credit for being able to level with the industry groups and move, in her words, “beyond the defensive position into pushing for proactive, thoughtful,...